Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sinopharm Group Co Ltd Class H (HK:1099)
HKEX:1099
Sinopharm Group Co (1099) Stock Price & Analysis
0 Followers
1099 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$17.44 - HK$26.64
Previous CloseHK$21.95
Volume7.26M
Average Volume (3M)5.81M
Market Cap
HK$68.45B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.8
Beta0.47
Next Earnings
Aug 26, 2024EPS Estimate
HK$1.54Next Dividend Ex-Date
Jun 17, 2024Dividend Yield4.08%
Share Statistics
EPS (TTM)3.20
Shares Outstanding1,341,810,740
10 Day Avg. Volume11,391,000
30 Day Avg. Volume5,806,344
Standard Deviation0.10
R-Squared0.22
Alpha-0.00466
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$28.16Price Target Upside28.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Sinopharm Group Co News
Bulls Say, Bears Say
Bulls Say
Financial HealthImprovements in Sinopharm's accounts receivable days are anticipated, which is likely to have a positive impact on the share price.
Government Policy ImpactGovernment initiatives requiring state-owned enterprises to increase their market cap have been beneficial for Sinopharm's share price.
Market Share GrowthSinopharm is expected to expand its market share due to industry consolidation and government policies.
Bears Say
Financial PerformanceEarnings forecasts are lowered to account for pricing pressure from government actions.
RegulationPrice cuts by the government may negatively impact Sinopharm.
Revenue And Earnings TrendChina National Accord's reported revenue and earnings trends indicate no growth and a decline, respectively.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
15.65% Mutual Funds
8.91% Other Institutional Investors
75.44% Public Companies and
Individual Investors
1099 FAQ
What was Sinopharm Group Co Ltd Class H’s price range in the past 12 months?
Sinopharm Group Co Ltd Class H lowest stock price was HK$17.44 and its highest was HK$26.64 in the past 12 months.
What is Sinopharm Group Co Ltd Class H’s market cap?
Currently, no data Available
When is Sinopharm Group Co Ltd Class H’s upcoming earnings report date?
Sinopharm Group Co Ltd Class H’s upcoming earnings report date is Aug 26, 2024 which is in 98 days.
How were Sinopharm Group Co Ltd Class H’s earnings last quarter?
Sinopharm Group Co Ltd Class H released its earnings results on Apr 26, 2024. The company reported HK$0.497 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.497.
Is Sinopharm Group Co Ltd Class H overvalued?
According to Wall Street analysts Sinopharm Group Co Ltd Class H’s price is currently Undervalued.
Does Sinopharm Group Co Ltd Class H pay dividends?
Sinopharm Group Co Ltd Class H pays a Annually dividend of HK$0.94 which represents an annual dividend yield of 4.08%. See more information on Sinopharm Group Co Ltd Class H dividends here
What is Sinopharm Group Co Ltd Class H’s EPS estimate?
Sinopharm Group Co Ltd Class H’s EPS estimate is HK$1.54.
How many shares outstanding does Sinopharm Group Co Ltd Class H have?
Sinopharm Group Co Ltd Class H has 1,341,810,800 shares outstanding.
What happened to Sinopharm Group Co Ltd Class H’s price movement after its last earnings report?
Sinopharm Group Co Ltd Class H reported an EPS of HK$0.497 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.92%.
Which hedge fund is a major shareholder of Sinopharm Group Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:1099
---
Sinopharm Group Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$28.16 (28.28% Upside)
HK$28.16 (28.28% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.71%
12-Months-Change
Fundamentals
Return on Equity
12.57%
Trailing 12-Months
Asset Growth
3.02%
Trailing 12-Months
Company Description
Sinopharm Group Co Ltd Class H
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment is distributes medical devices, financial leasing ,production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
---
1099 Stock 12 Month Forecast
Average Price Target
HK$28.16
▲(28.28% Upside)
Technical Analysis
Sinopharm Group Co
―
Takeda Pharmaceutical Company
―
Merck & Company
―
AstraZeneca
―
AbbVie
―
Best Analysts Covering 1099
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+10.45%
reiterated a buy rating 2 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.45% per trade.
---